help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neviere, R.
Right arrow Articles by Wattel, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neviere, R.
Right arrow Articles by Wattel, F.

Am. J. Respir. Crit. Care Med., Vol 154, No. 6, 12 1996, 1684-1688.

The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients

R Neviere, D Mathieu, JL Chagnon, N Lebleu and F Wattel
Service de Reanimation Medicale et Medecine Hyperbare, Hopital Calmette, Lille, France.

To test the hypothesis whether or not dobutamine or dopamine infusion increases gastric mucosal perfusion, a prospective randomized crossover trial was conducted on 10 septic patients in the intensive care unit of a university hospital. Systemic hemodynamic, oxygen transport, and gastric perfusion assessed by gastric intramucosal pH and laser Doppler flowmetry were measured at baseline and after administration of dobutamine or dopamine (5 micrograms/kg/min). Both increased oxygen transport. In response to dobutamine, gastric mucosal blood flow increased (+32 +/- 14% from baseline; p < 0.05), gastric tonometered PCO2 and gastric arterial PCO2 difference decreased (58 +/- 7 versus 52 +/- 7 mm Hg; p < 0.05; 16.8 +/- 7.0 versus 10.5 +/- 7.2 mm Hg; p < 0.05), and intramucosal pH increased (7.23 +/- 0.05 versus 7.29 +/- 0.06; p < 0.05). In response to dopamine, gastric mucosal blood flow decreased (-28 +/- 8% from baseline; p < 0.05), gastric tonometered PCO2, gastric-arterial PCO2 difference, and calculated intramucosal pH were unchanged (58 +/- 7 versus 61 +/- 9 mm Hg, ns; 16.8 +/- 7.0 versus 18.9 +/- 8.4 mm Hg, ns; 7.24 +/- 0.05 versus 7.21 +/- 0.06, ns). We speculated that despite an oxygen transport increase, dobutamine and dopamine have affected differently gastric mucosal perfusion in septic patients.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Raddatz, D. Kubulus, J. Winning, I. Bauer, S. Pradarutti, B. Wolf, S. Kreuer, and H. Rensing
Dobutamine Improves Liver Function after Hemorrhagic Shock through Induction of Heme Oxygenase-1
Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 198 - 207.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Y. A. Debaveye and G. H. Van den Berghe
Is There Still a Place for Dopamine in the Modern Intensive Care Unit?
Anesth. Analg., February 1, 2004; 98(2): 461 - 468.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Lisbon
Dopexamine, Dobutamine, and Dopamine Increase Splanchnic Blood Flow: What Is the Evidence?
Chest, May 1, 2003; 123(5_suppl): 460S - 463S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. O. Heard
Gastric Tonometry: The Hemodynamic Monitor of Choice (Pro)
Chest, May 1, 2003; 123(5_suppl): 469S - 474S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. M. Hameed and S. M. Cohn
Gastric Tonometry: The Role of Mucosal pH Measurement in the Management of Trauma
Chest, May 1, 2003; 123(5_suppl): 475S - 481S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. L. Holmes and K. R. Walley
Bad Medicine: Low-Dose Dopamine in the ICU
Chest, April 1, 2003; 123(4): 1266 - 1275.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Agusti, J. I. Elizalde, R. Adalia, G. Martinez-Palli, J. C. Garcia-Valdecasas, J. M. Pique, and P. Taura
The Effects of Vasoactive Drugs on Hepatic Blood Flow Changes Induced by CO2 Laparoscopy: An Animal Study
Anesth. Analg., November 1, 2001; 93(5): 1121 - 1126.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. MEIER-HELLMANN, K. REINHART, D. L. BREDLE, and S. G. SAKKA
Therapeutic Options for the Treatment of Impaired Gut Function
J. Am. Soc. Nephrol., February 1, 2001; 12(90001): 65S - 69.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
L.-M. JOLY, M. MONCHI, A. CARIOU, J.-D. CHICHE, F. BELLENFANT, F. BRUNET, and J.-F. DHAINAUT
Effects of Dobutamine on Gastric Mucosal Perfusion and Hepatic Metabolism in Patients with Septic Shock
Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 1983 - 1986.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. BOCQUILLON, D. MATHIEU, R. NEVIERE, N. LEFEBVRE, X. MARECHAL, and F. WATTEL
Gastric Mucosal pH and Blood Flow during Weaning from Mechanical Ventilation in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1555 - 1561.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. CRETEUR, D. DE BACKER, and J.-L. VINCENT
A Dobutamine Test Can Disclose Hepatosplanchnic Hypoperfusion in Septic Patients
Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 839 - 845.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1996 American Thoracic Society